相似文献/References:
[1]陈炜,许贞蓉.表观遗传学与代谢性心血管疾病的研究进展[J].心血管病学进展,2019,(6):902.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.016]
CHEN Wei,XU Zhenrong.Epigenetics and Cardiometabolic Disease[J].Advances in Cardiovascular Diseases,2019,(3):902.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.016]
[2]占小锋 张长磊 李刚.β肾上腺素受体阻滞剂对甘油三酯代谢的影响及其作用机制的阐述[J].心血管病学进展,2019,(9):1298.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.029]
ZHAN Xiaofeng,ZHANG Changlei,LI Gang.Effect of -adrenergic Receptor Blockers on Triglyceride Metabolism and Mechanism[J].Advances in Cardiovascular Diseases,2019,(3):1298.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.029]
[3]李莎 熊峰.胰岛素抵抗与心血管疾病研究进展[J].心血管病学进展,2019,(9):1307.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.032]
Li ShaXiong Feng.Insulin Resistance and Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(3):1307.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.032]
[4]位晨晨,钟明.糖尿病心肌病的发病机制[J].心血管病学进展,2020,(2):135.[doi:10.16806/j.cnki.issn.1004-3934.20.02.009]
WEI Chenchen,ZHONG Ming.Pathogenesis of Diabetic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2020,(3):135.[doi:10.16806/j.cnki.issn.1004-3934.20.02.009]
[5]任蕾 夏芳芳 戴红艳.血管生成素样蛋白6在心血管病方面的研究进展[J].心血管病学进展,2020,(4):388.[doi:10.16806/j.cnki.issn.1004-3934.20.04.015]
REN Lei,XIA FangFang,DAI HongYan.Relationship Between ANGPTL6 and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(3):388.[doi:10.16806/j.cnki.issn.1004-3934.20.04.015]
[6]杨晓倩 秦莉 张艺文 童兰 汪汉.糖皮质激素与心血管疾病[J].心血管病学进展,2020,(4):404.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.019]
YANG Xiaoqian,QIN Li,ZHANG Yiwen,et al.Glucocorticoid and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(3):404.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.019]
[7]樊德慧 金娟 韩宇博 田苗 刘莉.利钠肽与代谢综合征的研究进展[J].心血管病学进展,2020,(10):1074.[doi:10.16806/j.cnki.issn.1004-3934.20.10.018]
FAN Dehui,JIN Juan,HAN Yubo,et al.Research Progress of Natriuretic Peptide and Metabolic Syndrome[J].Advances in Cardiovascular Diseases,2020,(3):1074.[doi:10.16806/j.cnki.issn.1004-3934.20.10.018]
[8]王晓琪 苏冠华.高尿酸血症和心力衰竭的病理生理机制、治疗和预后价值[J].心血管病学进展,2021,(9):780.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
WANG Xiaoqi,SU Guanhua.Pathophysiological Mechanism, Treatment and Prognostic Value of Hyperuricemia and Heart Failure[J].Advances in Cardiovascular Diseases,2021,(3):780.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
[9]谭思华 周晓莉.非酒精性脂肪肝与冠状动脉粥样硬化及炎症的研究进展[J].心血管病学进展,2023,(5):439.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.013]
TAN Sihua,ZHOU Xiaoli.Association of Non-Alcoholic Fatty Liver Disease with Coronary Atherosclerosis and Inflammation[J].Advances in Cardiovascular Diseases,2023,(3):439.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.013]
[10]徐明成 赵玉娟.甘油三酯葡萄糖指数对动脉粥样硬化性心血管疾病的预测价值[J].心血管病学进展,2023,(9):810.[doi:10.16806/j.cnki.issn.1004-3934.202.09.010]
Xu Mingcheng,ZHAO Yujuan.Predictive Value of Triglyceride Glucose Index in Atherosclerotic Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2023,(3):810.[doi:10.16806/j.cnki.issn.1004-3934.202.09.010]
[11]廖丽萍 周跟东 张晓红.血清甘油三酯葡萄糖乘积指数与代谢性疾病的研究进展[J].心血管病学进展,2020,(11):1189.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
[12]魏罗嫚,杨玉亭,和丽丽,等.甘油三酯葡萄糖乘积指数在心力衰竭中的研究进展[J].心血管病学进展,2023,(8):724.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.012]
WEI Luoman,YANG Yuting,HE Lili,et al.Advances of Triglyceride Glucose Index in Heart Failure[J].Advances in Cardiovascular Diseases,2023,(3):724.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.012]